Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ergomed plc is a global company dedicated to providing specialized services to the pharmaceutical and biotechnology industry. Founded in 1997, Ergomed has grown to become a key player in clinical development, trial management, and pharmacovigilance. The company offers a comprehensive suite of services including Phase I-IV clinical trial services, and post-approval drug safety and medical information services through its PrimeVigilance division. Ergomed is committed to supporting its clients in bringing new therapies to patients safely and efficiently, leveraging its deep expertise and global infrastructure. Following its acquisition by Permira in late 2023, Ergomed continues to focus on growth and innovation in the Contract Research Organization (CRO) and Pharmacovigilance (PV) sectors.
The Guildford headquarters serves as the central hub for Ergomed's global operations, strategic decision-making, corporate governance, and administrative functions. It supports the company's worldwide network of clinical research and pharmacovigilance activities.
Located within the Surrey Research Park, a major centre for technology and innovation, providing a dynamic and collaborative environment. The facilities are modern and designed to support a high-performance workforce.
Ergomed's HQ fosters a professional, collaborative, and science-driven work culture. Employees are engaged in high-impact projects within the pharmaceutical services sector, emphasizing expertise, quality, and patient focus. The environment encourages continuous learning and development.
The UK headquarters is significant due to its strategic location in a key European life sciences hub, facilitating access to talent, clients, and regulatory bodies. It anchors Ergomed's global presence and commitment to excellence in clinical research and pharmacovigilance.
Ergomed operates globally, providing comprehensive clinical research and pharmacovigilance services across North America, Europe, the Middle East, and Asia. Its worldwide infrastructure supports international clinical trials, regulatory submissions, drug safety monitoring, and medical information services, enabling clients to navigate complex multinational healthcare landscapes effectively. The company leverages local expertise in numerous countries to ensure compliance and operational excellence.
1 Occam Court, Surrey Research Park
Guildford
Surrey
United Kingdom
Address: PrimeVigilance Inc., 4819 Emperor Boulevard, Suite 400, Durham, NC 27703, USA
Provides direct access to the significant US pharmaceutical and biotech market, facilitating client engagement and operational execution in North America.
Address: Ergomed GmbH, THE SQUAIRE 12, Am Flughafen, 60549 Frankfurt am Main, Germany
Strengthens Ergomed's presence in DACH region (Germany, Austria, Switzerland) and wider EU, supporting multi-country clinical studies and PV compliance.
Address: Ergomed Sp. z o.o., Jasnogórska 1, 31-358 Kraków, Poland
Facilitates access to patient populations and clinical sites in CEE, a key region for clinical trial recruitment, and provides a base for regional service delivery.
Address: Ergomed d.o.o., Milana Sachsa 1, 10000 Zagreb, Croatia
Leverages local talent and provides strategic support for clinical research activities in Southeastern Europe and beyond.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ERGOMED' leadership includes:
ERGOMED has been backed by several prominent investors over the years, including:
The past year featured key leadership appointments at Ergomed, with Richard Barfield confirmed as CEO and Jonathan West joining as CFO, steering the company through its acquisition by Permira and into its next phase of growth. Dr. Miroslav Reljanović transitioned from his role as Executive Chairman.
Discover the tools ERGOMED uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ergomed typically uses standard corporate email formats for its employees. The most common formats are likely based on employee names, such as the first initial followed by the last name, or the full first name separated from the last name by a dot, all preceding '@ergomedplc.com'.
Common formats include: [firstinitial][last]@ergomedplc.com (e.g., jsmith@ergomedplc.com) and [first].[last]@ergomedplc.com (e.g., john.smith@ergomedplc.com).
Format
jsmith@ergomedplc.com
Example
75%
Success rate
Permira Official Website • November 14, 2023
Ergomed plc announced the completion of its acquisition by funds advised by Permira. This strategic move, valued at approximately £703.1 million, is expected to support Ergomed's continued growth and expansion as a leading global provider of specialized pharmaceutical services....more
Ergomed Company Announcement / London Stock Exchange • September 7, 2023
Ergomed plc announced the appointment of Richard Barfield as its permanent Chief Executive Officer, effective September 7, 2023. Barfield had been serving as Interim CEO since January 2023. Concurrently, Jonathan West, who joined in July 2023 as CFO designate, formally assumed the CFO role....more
Ergomed Website News • February 28, 2024
Ergomed announced new senior appointments to bolster its therapeutic expertise in rare diseases and oncology. Dr. Su SAMSAN joins as Senior Vice President, Head of Rare Disease and Christa VAN HARDEVELD as Senior Vice President, Head of Oncology Project Management, reinforcing Ergomed’s commitment to these critical areas....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ERGOMED, are just a search away.